Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TeVido BioDevices was an Austin, Texas regenerative medicine company focused on autologous, patient-specific pigment cell grafts and 3D bioprinted tissue products for reconstructive and aesthetic procedures. The company’s core approach combined a patient’s own living skin cells with biomanufacturing and 3D bioprinting techniques to restore pigmentation in conditions such as vitiligo, scars, and other forms of hypopigmentation. TeVido also promoted a 3D bioprinted nipple-areola complex program for breast reconstruction after mastectomy. Public company-profile sources describe it as having operated an FDA-registered, cGMP-compliant lab and at various times as clinical stage or commercial stage, but more recent business databases list the company as out of business. Overall, TeVido appears to have been a private regenerative medicine startup centered on personalized skin-color restoration and reconstructive tissue-engineering applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TeVido BioDevices.